Pax6, an evolutionarily conserved transcription factor, is expressed in the
murine and zebrafish embryonic pituitary, but its role in pituitary develo
pment and endocrine function has not been described, To study the role of P
ax6 in vivo, we examined Pax6 mutant mouse (Sey(Neu)) pituitaries. Mice hom
ozygous for the Sey(Neu) mutation die at birth; therefore, we examined pept
ide hormone expression by the differentiated pituitary cell types as well a
s developmental marker expression in the intermediate and anterior lobes of
the embryonic pituitary, GH- and PRL-immunopositive cells appear severely
decreased in an outbred ICR background at embryonic d 17.5, although mRNA e
xpression of these peptide hormones is present, as is expression of other p
ituitary markers. This suggests that pituitary cell types are able to diffe
rentiate in mutant embryos, To identify the cellular or physiologic mechani
sm responsible for less GH- and PRL-immunoreactivity in Pax6 mutant mice, w
e tested serum levels of GH and PRL, Pax6 homozygous mutant mice have CH se
rum levels one fifth that of controls at embryonic d 17.5, and one-third th
at of controls at postnatal d 0, PRL serum levels, which are very low durin
g embryonic and neonatal stages, were below assay detection limits in both
the wild-type and mutant groups. Taken together, these data suggest that Pa
x6 is not essential for pituitary differentiation, but rather functions to
establish appropriate neonatal homeostatic levels of GH and PRL, possibly t
hrough regulation of translational or secretory mechanisms.